Aditya Birla SL Quant Fund
The Scheme seeks to generate long term capital appreciation by investing in equity and equity related securities based on quant model theme. The Scheme does not guarantee/indicate any returns. There is no assurance that the investment objective of the Scheme will be achieved.
Growthvine rating: 2/5 — ranked #108 of 186 in category.
Fund basics
| Category | Equity: Thematic |
|---|
| NAV | ₹9.20 (as of 2026-10-23) |
|---|
| AUM | ₹1,855 Cr |
|---|
| Expense ratio | 1.77% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Harish Krishnan |
|---|
| Exit load | 0.5% for redemption within 90 days |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | −23.44% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 69.1% of NIFTY Alpha 50's upside and 70.3% of its downside.
Market cap allocation
| Large cap | 54.7% |
|---|
| Mid cap | 40.3% |
|---|
| Small cap | 5.0% |
|---|
Concentration
| Top 5 holdings | 21.8% |
|---|
| Top 10 holdings | 39.9% |
|---|
| Total holdings | 44 |
|---|
Top holdings
- Marico Limited — 4.8%
- Torrent Pharmaceuticals Ltd. — 4.6%
- Apollo Hospitals Enterprises Ltd. — 4.3%
- Nestle India Ltd. — 4.1%
- Laurus Labs Limited — 4.0%
- Grasim Industries Ltd — 4.0%
- Federal Bank Ltd. — 4.0%
- Sun Pharmaceutical Industries Ltd. — 3.5%
- Hindalco Industries Ltd. — 3.5%
- Glenmark Pharmaceuticals ltd — 3.0%
Top sectors
- Pharma & Biotech — 19.6%
- Automobile — 12.6%
- Industrial Products — 11.0%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −9.3% | Q3 | #108 of 167 |
| 2025 | 6.4% | Q2 | #45 of 132 |